A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers.

Hao Huang Duoliang Qiu Zhengyang Zhou Biaobiao Wu Lening Shao YuWei Pu Tengfei He Yongyou Wu Dawei Cui Fengyun Zhong

Published in: Discover. Oncology (2023)

These results showed that the levels of CDKN1B were considerably different in a number of cancer tissues, offering a potential future target for cancer therapy.

Keyphrases

papillary thyroid
cancer therapy
squamous cell
endothelial cells
gene expression
drug delivery
lymph node metastasis
squamous cell carcinoma
risk assessment
cell death
signaling pathway
current status
human health
climate change